July 28, 2020
Breakthrough Properties has secured a 263,500-square-foot full-building office lease with gene editing company CRISPR Therapeutics at The 105, a laboratory building project in Boston’s Seaport neighborhood.
Located at 105 West First St., the LEED Gold certified building is slated for completion in early 2022. The project was designed by the Payette architecture firm and is located nearby the Red Line’s Broadway Station. Amenities will include a fitness facility and outdoor terraces accessible from two floors.
Breakthrough Properties was started in 2019 by Tishman Speyer and biotechnology investment firm Bellco Capital. Breakthrough was formed to acquire, develop and operate life science properties in leading technology centers around the world.
Cushman & Wakefield represented CRISPR in the lease transaction. Breakthrough was represented by Newmark Knight Frank.
For comments, questions or concerns, please contact David Cohen